“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
Yuval Horn and Paz Abercohen of Horn & Co. acted as Israeli counsel to Protalix BioTherapeutics, Inc. (NYSE: PLX) in a $9 Million private notes exchange agreement, and a $10 Million private placement of the company’s Secured Convertible Notes.
